(Q38594555)

English

Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy

scientific article published on 28 September 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 September 2017

Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy (English)

1 reference

Europe PubMed Central

4 September 2017

0 references

0 references

object named as

Lars Navér

16

0 references

23

object named as

Anders Tegnell

1 reference

Europe PubMed Central

4 September 2017

Karin Tegmark Wisell

22

object named as

Karin Tegmark Wisell

1 reference

Europe PubMed Central

4 September 2017

Anders Blaxhult

7

object named as

Anders Blaxhult

1 reference

Europe PubMed Central

4 September 2017

2

object named as

Jan Albert

1 reference

Europe PubMed Central

4 September 2017

author name string

Hans Gaines

1

1 reference

Europe PubMed Central

4 September 2017

Maria Axelsson

3

1 reference

Europe PubMed Central

4 September 2017

Torsten Berglund

4

1 reference

Europe PubMed Central

4 September 2017

Magnus Gisslén

5

1 reference

Europe PubMed Central

4 September 2017

Anders Sönnerborg

6

1 reference

Europe PubMed Central

4 September 2017

Gordana Bogdanovic

8

1 reference

Europe PubMed Central

4 September 2017

Maria Brytting

9

1 reference

Europe PubMed Central

4 September 2017

Christina Carlander

10

1 reference

Europe PubMed Central

4 September 2017

Leo Flamholc

11

1 reference

Europe PubMed Central

4 September 2017

Per Follin

12

1 reference

Europe PubMed Central

4 September 2017

Axana Haggar

13

1 reference

Europe PubMed Central

4 September 2017

Per Hagstam

14

1 reference

Europe PubMed Central

4 September 2017

Marcus Johansson

15

1 reference

Europe PubMed Central

4 September 2017

Jenny Persson Blom

17

1 reference

Europe PubMed Central

4 September 2017

Agneta Samuelson

18

1 reference

Europe PubMed Central

4 September 2017

Helena Ström

19

1 reference

Europe PubMed Central

4 September 2017

Martin Sundqvist

20

1 reference

Europe PubMed Central

4 September 2017

Veronica Svedhem Johansson

21

1 reference

Europe PubMed Central

4 September 2017

Rigmor Thorstensson

24

1 reference

Europe PubMed Central

4 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

28 September 2015

1 reference

Europe PubMed Central

4 September 2017

Infectious diseases (London, England)

1 reference

Europe PubMed Central

4 September 2017

48

1 reference

Europe PubMed Central

4 September 2017

2

1 reference

Europe PubMed Central

4 September 2017

93-98

1 reference

Europe PubMed Central

4 September 2017

Antibody response in primary human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Viral dynamics in primary HIV-1 infection. Karolinska Institutet Primary HIV Infection Study Group.

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Risk of HIV transmission from patients on antiretroviral therapy: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Clinical picture of primary HIV infection presenting as a glandular-fever-like illness

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

The detection of acute HIV infection

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS.

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Zidovudine treatment in patients with primary (acute) human immunodeficiency virus type 1 infection: a randomized, double-blind, placebo-controlled trial. DATRI 002 Study Group. Division of AIDS Treatment Research Initiative

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

A novel acute HIV infection staging system based on 4th generation immunoassay

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Delayed HIV diagnosis common in Sweden, 2003-2010

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Incubation periods of acute respiratory viral infections: a systematic review.

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Persistently negative HIV-1 antibody enzyme immunoassay screening results for patients with HIV-1 infection and AIDS: serologic, clinical, and virologic results. Seronegative AIDS Clinical Study Group.

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Human immunodeficiency virus infection and AIDS in a person with negative serology

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Performance evaluation of a new fourth-generation HIV combination antigen-antibody assay

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Performance evaluation of the new fully automated human immunodeficiency virus antigen-antibody combination assay designed for blood screening

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure (2011).

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Seroconversion following nonoccupational postexposure prophylaxis against HIV.

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

HIV seroreversion time in HIV-1-uninfected children born to HIV-1-infected mothers in Malawi

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Evaluation and management of the infant exposed to HIV-1 in the United States

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis.

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Early diagnosis of in utero and intrapartum HIV infection in infants prior to 6 weeks of age.

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013.

1 reference

https://api.crossref.org/works/10.3109%2F23744235.2015.1089593

21 January 2018

Identifiers

10.3109/23744235.2015.1089593

1 reference

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

4 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38594555&oldid=2136998250"